Probability of Achieving BMD Treatment Targets with Abaloparatide and Teriparatide Over 18 Months and Sequential Abaloparatide vs Placebo Followed by Alendronate Over 3.5 Years-MedSci.cn

Probability of Achieving BMD Treatment Targets with Abaloparatide and Teriparatide Over 18 Months and Sequential Abaloparatide vs Placebo Followed by Alendronate Over 3.5 Years

Cosman, F; Mitlak, B; Wang, YM; Caminis, J; Moreira, C; Lewiecki, M; Cummings, S

JOURNAL OF BONE AND MINERAL RESEARCH, 2023; 38 (): 324

科室
- - 订阅+
  - 更多科室
工具
服务